Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Novartis Ag (NVSEF) Pension (2017 - 2025)

Historic Pension for Novartis Ag (NVSEF) over the last 9 years, with Q4 2025 value amounting to $1.6 billion.

  • Novartis Ag's Pension rose 407.38% to $1.6 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $1.6 billion, marking a year-over-year increase of 407.38%. This contributed to the annual value of $1.6 billion for FY2025, which is 407.38% up from last year.
  • According to the latest figures from Q4 2025, Novartis Ag's Pension is $1.6 billion, which was up 407.38% from $1.6 billion recorded in Q4 2024.
  • In the past 5 years, Novartis Ag's Pension registered a high of $2.6 billion during Q4 2021, and its lowest value of $1.6 billion during Q4 2024.
  • Over the past 5 years, Novartis Ag's median Pension value was $1.7 billion (recorded in 2022), while the average stood at $1.9 billion.
  • In the last 5 years, Novartis Ag's Pension plummeted by 3473.48% in 2022 and then soared by 533.95% in 2023.
  • Novartis Ag's Pension (Quarter) stood at $2.6 billion in 2021, then tumbled by 34.73% to $1.7 billion in 2022, then rose by 5.34% to $1.8 billion in 2023, then decreased by 13.44% to $1.6 billion in 2024, then increased by 4.07% to $1.6 billion in 2025.
  • Its Pension stands at $1.6 billion for Q4 2025, versus $1.6 billion for Q4 2024 and $1.8 billion for Q4 2023.